Tinidazole (Fasigyn), a new drug which is active in vitro and in vivo against Entamoeba histolytica, was used in 30 Korean patients with acute and chronic intestinal amoebiasis. In aute amoebic dysentry eight of ten patients given tinidazole 150 mg q.i.d. for 10 days were cured clinically and parasitologically. In chronic intestinal amoebiasis, the parasitological cure was obtained 6 out of 10 patients given150 mg q.i.d. for 10 days and 8 out of 10 in patients given 300 mg q.i.d. for 7 days. Tinidazole is well tolerated and is free from serious toxicity. There was no significant alteration in blood count, liver function tests and urine analysis of any of the patients treated with tinidazole.
parasitology-protozoa-Entamoeba histolytica ; chemotherapy-Tinidazole ; drug ; Tinidazole

This review dealt with biology, host-parasite relationship, symptomatology, epidemiology, diagnosis, treatment of Entamoeba histolytica infection and free livng amoeba.
parasitology-protozoa ; Entamoeba histolytica ; Entabmoeba gingivalis ; Trichomonas tenax ; Naegleria sp. ; Naegleria fowleri ; Acanthamoeba lenticulata ; Acanthamoeba sp. ; biology ; epidemiology ; diagnosis ; chemotherapy ; metronidazole ; onidazole ; tinidazole